FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Lee

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Lymphocyte Activation

Anatomy

Disorders

Experimental Leukemias

Co-author Network

Publications

TOP 3
Sanjay Kumar; Jeffrey Boehm; John Lee
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases.
Zehong Wan; Jeffrey C Boehm; Michael J Bower; Shouki Kassis; John Lee; Baoguang Zhao; Jerry L Adams
N-Phenyl-N-purin-6-yl ureas: the design and synthesis of p38alpha MAP kinase inhibitors.
Sanjay Kumar; Charles R Hanning; Michael Brigham-Burke; David J Rieman; Ruth Lehr; Sanjay S Khandekar; Robert B Kirkpatrick; Gilbert F Scott; John Lee; Frank J Lynch; Wentao Gao; Andrea Gambotto; Michael T Lotze
Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Lee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Sanjay Kumar; Jeffrey Boehm; John Lee
p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases.
Nature reviews. Drug discovery 2003;2(9):717-26.
2003: Zehong Wan; Jeffrey C Boehm; Michael J Bower; Shouki Kassis; John Lee; Baoguang Zhao; Jerry L Adams
N-Phenyl-N-purin-6-yl ureas: the design and synthesis of p38alpha MAP kinase inhibitors.
Bioorganic & medicinal chemistry letters 2003;13(6):1191-4.
2002: Sanjay Kumar; Charles R Hanning; Michael Brigham-Burke; David J Rieman; Ruth Lehr; Sanjay S Khandekar; Robert B Kirkpatrick; Gilbert F Scott; John Lee; Frank J Lynch; Wentao Gao; Andrea Gambotto; Michael T Lotze
Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.
Cytokine 2002;18(2):61-71.
2002: Haisong Ju; Sandhya S Nerurkar; Charles F Sauermelch; Alan R Olzinski; Rosanna Mirabile; Dawn Zimmerman; John Lee; Jerry Adams; Joseph Sisko; Marinella Berova; Robert N Willette
Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury.
The Journal of pharmacology and experimental therapeutics 2002;301(1):15-20.
2001: Jerry L Adams; Jeffrey C Boehm; TF Gallagher; Shouki Kassis; Edward F Webb; R Hall; M Sorenson; R Garigipati; Don E Griswold; John Lee
Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity.
Bioorganic & medicinal chemistry letters 2001;11(21):2867-70.
2001: Sanjay Kumar; JR Connor; RA Dodds; WS Halsey; M Van Horn; J Mao; Ganesh Sathe; P Mui; Pankaj Agarwal; AM Badger; John Lee; Maxine Gowen; Michael W Lark
Identification and initial characterization of 5000 expressed sequenced tags (ESTs) each from adult human normal and osteoarthritic cartilage cDNA libraries.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2001;9(7):641-53.
2001: T M Behr; Sandhya S Nerurkar; Allen H Nelson; Robert W Coatney; Tina N Woods; Anthony C Sulpizio; Sudeep Chandra; David P Brooks; Sanjay Kumar; John Lee; Eliot ohlstein; Christiane E Angermann; Jerry L Adams; J Sisko; Jonathan D Sackner-Bernstein; Robert N Willette
Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction.
Circulation 2001;104(11):1292-8.
2001: Sanjay Kumar; Bartholomew Votta; David J Rieman; AM Badger; Maxine Gowen; John Lee
IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase.
Journal of cellular physiology 2001;187(3):294-303.
2001: Frank C Barone; Elaine A Irving; A M Ray; John Lee; Shouki Kassis; Sanjay Kumar; AM Badger; Jeffrey J Legos; Joseph A Erhardt; Eliot ohlstein; A Jackie Hunter; David C Harrison; KL Philpott; B R Smith; Jerry L Adams; Andrew A Parsons
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.
Medicinal research reviews 2001;21(2):129-45.
2001: Frank C Barone; Elaine A Irving; A M Ray; John Lee; Shouki Kassis; Sanjay Kumar; AM Badger; Ray F White; M J McVey; Jeffrey J Legos; Joseph A Erhardt; Allen H Nelson; Eliot ohlstein; A Jackie Hunter; K Ward; B R Smith; Jerry L Adams; Andrew A Parsons
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia.
The Journal of pharmacology and experimental therapeutics 2001;296(2):312-21.
2001: Jerry L Adams; AM Badger; S Kumar; John Lee
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
Progress in medicinal chemistry 2001;38():1-60.
2000: Tian-Li Yue; Juan-li Gu; C Wang; A D Reith; John Lee; Rosanna Mirabile; R Kreutz; Yibin Wang; B Maleeff; Andrew A Parsons; Eliot ohlstein
Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.
The Journal of biological chemistry 2000;275(48):37895-901.
2000: AM Badger; Amy K Roshak; Michael N Cook; TM Newman-Tarr; Barbara A Swift; Karey Carlson; JR Connor; John Lee; Maxine Gowen; Michael W Lark; Sanjay Kumar
Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2000;8(6):434-43.
2000: David C Underwood; RR Osborn; S Bochnowicz; Edward F Webb; David J Rieman; John Lee; Anne M Romanic; Jerry L Adams; Douglas W P Hay; Don E Griswold
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.
American journal of physiology. Lung cellular and molecular physiology 2000;279(5):L895-902.
2000: Shouki Kassis; T Melhuish; R S Annan; S L Chen; John Lee; George P Livi; Caretha L Creasy
Saccharomyces cerevisiae Yak1p protein kinase autophosphorylates on tyrosine residues and phosphorylates myelin basic protein on a C-terminal serine residue.
The Biochemical journal 2000;348 Pt 2():263-72.
2000: John Lee; S Kumar; Don E Griswold; David C Underwood; B J Votta; Jerry L Adams
Inhibition of p38 MAP kinase as a therapeutic strategy.
Immunopharmacology 2000;47(2-3):185-201.
2000: David C Underwood; RR Osborn; Charles J Kotzer; Jerry L Adams; John Lee; Edward F Webb; D C Carpenter; S Bochnowicz; H C Thomas; Douglas W P Hay; Don E Griswold
SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.
The Journal of pharmacology and experimental therapeutics 2000;293(1):281-8.
2000: Tian-Li Yue; C Wang; Juan-li Gu; Xin L Ma; S Kumar; John Lee; Giora Z Feuerstein; H Thomas; B Maleeff; Eliot ohlstein
Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart.
Circulation research 2000;86(6):692-9.
2000: AM Badger; Don E Griswold; RD Kapadia; Simon Blake; Barbara A Swift; Sandra J Hoffman; George B Stroup; E Webb; David J Rieman; Maxine Gowen; Jeffrey C Boehm; Jerry L Adams; John Lee
Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis.
Arthritis and rheumatism 2000;43(1):175-83.
1999: Sanjay Kumar; M S Jiang; J L Adams; John Lee
Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase.
Biochemical and biophysical research communications 1999;263(3):825-31.
1999: Sanjay Kumar; A T Hand; JR Connor; RA Dodds; P J Ryan; J J Trill; S M Fisher; Mark E Nuttall; D B Lipshutz; C Zou; Shing-Mei Hwang; Bartholomew Votta; Ian E James; David J Rieman; Maxine Gowen; John Lee
Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions.
The Journal of biological chemistry 1999;274(24):17123-31.
1999: John Lee; Shouki Kassis; Sanjay Kumar; AM Badger; Jerry L Adams
p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials.
Pharmacology & therapeutics 1999;82(2-3):389-97.
1999: Xin L Ma; S Kumar; Feng Gao; CS Louden; Bernard L Lopez; Theodore A Christopher; C Wang; John Lee; Giora Z Feuerstein; Tian-Li Yue
Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.
Circulation 1999;99(13):1685-91.
1999: W Zhang; John Lee; S Kumar; Maxine Gowen
ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(4):528-35.
1998: Jerry L Adams; Jeffrey C Boehm; Shouki Kassis; PD Gorycki; Edward F Webb; R Hall; M Sorenson; John Lee; Andrew Ayrton; Don E Griswold; TF Gallagher
Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes.
Bioorganic & medicinal chemistry letters 1998;8(22):3111-6.
1998: RJ Gum; Megan M McLaughlin; Sanjay Kumar; Z Wang; Michael J Bower; John Lee; Jerry L Adams; George P Livi; E J Goldsmith; Peter Young
Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket.
The Journal of biological chemistry 1998;273(25):15605-10.
1997: Sanjay Kumar; PC McDonnell; RJ Gum; A T Hand; John Lee; Peter Young
Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles.
Biochemical and biophysical research communications 1997;235(3):533-8.
1997: Peter Young; Megan M McLaughlin; Sanjay Kumar; Shouki Kassis; Michael Doyle; Dean E McNulty; TF Gallagher; S Fisher; PC McDonnell; Steve Carr; Michael J Huddleston; G Seibel; T G Porter; George P Livi; Jerry L Adams; John Lee
Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site.
The Journal of biological chemistry 1997;272(18):12116-21.
1997: TF Gallagher; G L Seibel; Shouki Kassis; J T Laydon; M J Blumenthal; John Lee; D Lee; Jeffrey C Boehm; S M Fier-Thompson; J W Abt; M E Soreson; J M Smietana; R F Hall; R S Garigipati; P E Bender; Karl F Erhard; A J Krog; Glenn Hofmann; P L Sheldrake; PC McDonnell; Sanjay Kumar; Peter Young; Jerry L Adams
Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase.
Bioorganic & medicinal chemistry 1997;5(1):49-64.
1996: AM Badger; JN Bradbeer; Bartholomew Votta; John Lee; J L Adams; Don E Griswold
Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function.
The Journal of pharmacology and experimental therapeutics 1996;279(3):1453-61.
1996: S Kumar; M J Orsini; John Lee; P C McDonnell; CM Debouck; Peter Young
Activation of the HIV-1 long terminal repeat by cytokines and environmental stress requires an active CSBP/p38 MAP kinase.
The Journal of biological chemistry 1996;271(48):30864-9.
1996: Jeffrey C Boehm; J M Smietana; M E Sorenson; R S Garigipati; TF Gallagher; P L Sheldrake; JN Bradbeer; AM Badger; J T Laydon; John Lee; L M Hillegass; Don E Griswold; JJ Breton; MC Chabot-Fletcher; Jerry L Adams
1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.
Journal of medicinal chemistry 1996;39(20):3929-37.
1996: Don E Griswold; L M Hillegass; J O'Leary-Bartus; John Lee; J T Laydon; T J Torphy
Evaluation of human cytokine production and effects of pharmacological agents in a heterologous system in vivo.
Journal of immunological methods 1996;195(1-2):1-5.
1996: Megan M McLaughlin; S Kumar; P C McDonnell; S Van Horn; John Lee; George P Livi; Peter Young
Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase.
The Journal of biological chemistry 1996;271(14):8488-92.
1995: S Kumar; Megan M McLaughlin; P C McDonnell; John Lee; George P Livi; Peter Young
Human mitogen-activated protein kinase CSBP1, but not CSBP2, complements a hog1 deletion in yeast.
The Journal of biological chemistry 1995;270(49):29043-6.
1994: John Lee; J T Laydon; PC McDonnell; TF Gallagher; Sanjay Kumar; David Green; Dean E McNulty; M J Blumenthal; J R Heys; S W Landvatter
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis.
Nature 1994;372(6508):739-46.
1994: John Lee; U Prabhakar; Don E Griswold; D Dunnington; Peter Young; AM Badger
Low-molecular-weight TNF biosynthesis inhibitors: strategies and prospectives.
Circulatory shock 1994;44(3):97-103.
1994: U Prabhakar; D Lipshutz; J O Bartus; M J Slivjak; E F Smith; John Lee; K M Esser
Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor.
International journal of immunopharmacology 1994;16(10):805-16.
1993: John Lee; AM Badger; Don E Griswold; D Dunnington; A Truneh; Bartholomew Votta; John White; Peter Young; P E Bender
Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors.
Annals of the New York Academy of Sciences 1993;696():149-70.
1993: D L Olivera; J T Laydon; L Hillegass; AM Badger; John Lee
Effects of pyridinyl imidazole compounds on murine TNF-alpha production.
Agents and actions 1993;39 Spec No():C55-7.
1993: S Kassis; U Prabhakar; John Lee
Inhibition of interleukin-1 (IL-1) and tumor necrosis factor (TNF) production by pyridinyl imidazole compounds is independent of cAMP elevating mechanisms.
Agents and actions 1993;39 Spec No():C64-6.
1992: D L Olivera; K M Esser; John Lee; R G Greig; AM Badger
Beneficial effects of SK&F 105809, a novel cytokine-suppressive agent, in murine models of endotoxin shock.
Circulatory shock 1992;37(4):301-6.
1991: Don E Griswold; J R Connor; B J Dalton; John Lee; P Simon; L Hillegass; D J Sieg; N Hanna
Activation of the IL-1 gene in UV-irradiated mouse skin: association with inflammatory sequelae and pharmacologic intervention.
The Journal of investigative dermatology 1991;97(6):1019-23.
1991: Don E Griswold; P J Marshall; John Lee; Edward F Webb; L M Hillegass; J Wartell; J Newton; N Hanna
Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.
Biochemical pharmacology 1991;42(4):825-31.
1991: P J Marshall; Don E Griswold; J Breton; Edward F Webb; L M Hillegass; Henry M Sarau; J Newton; John Lee; P E Bender; N Hanna
Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
Biochemical pharmacology 1991;42(4):813-24.
1989: John Lee; Bartholomew Votta; Don E Griswold; N Hanna
Inhibitory effect of SK&F 86002 on monocyte IL-1 production.
Agents and actions 1989;27(3-4):280-1.
1989: S Kassis; John Lee; N Hanna
Effects of prostaglandins and cAMP levels on monocyte IL-1 production.
Agents and actions 1989;27(3-4):274-6.
1988: John Lee; A M Badger; W J Johnson
Human non-interferon macrophage activating factor: biological and biochemical characterization.
Advances in experimental medicine and biology 1988;239():217-21.
1988: John Lee; Don E Griswold; Bartholomew Votta; N Hanna
Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002.
International journal of immunopharmacology 1988;10(7):835-43.
1987: John Lee; M J Dimartino; Bartholomew Votta; N Hanna
Effect of auranofin treatment on aberrant splenic interleukin production in adjuvant arthritic rats.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(10):3268-74.
1986: John Lee; L Rebar; P Young; F W Ruscetti; N Hanna; G Poste
Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(4):1322-8.
1986: M J DiMartino; John Lee; AM Badger; K A Muirhead; C K Mirabelli; N Hanna
Antiarthritic and immunoregulatory activity of spirogermanium.
The Journal of pharmacology and experimental therapeutics 1986;236(1):103-10.
1985: John Lee; L Rebar; S Demuth; N Hanna
Suppressed IL-2 production and response in AA rats: role of suppressor cells and the effect of auranofin treatment.
The Journal of rheumatology 1985;12(5):885-91.
1985: D E Griswold; John Lee; G Poste; N Hanna
Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin.
The Journal of rheumatology 1985;12(3):490-7.
1982: John Lee; A J Hapel; J N Ihle
Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(6):2393-8.
1982: J N Ihle; L Rebar; J Keller; John Lee; A J Hapel
Interleukin 3: possible roles in the regulation of lymphocyte differentiation and growth.
Immunological reviews 1982;63():5-32.
1982: J N Ihle; L Enjuanes; John Lee; J Keller
The immune response to C-type viruses and its potential role in leukemogenesis.
Current topics in microbiology and immunology 1982;101():31-49.
1982: J N Ihle; John Lee
Possible immunological mechanisms in C-type viral leukemogenesis in mice.
Current topics in microbiology and immunology 1982;98():85-101.
1982: A J Hapel; John Lee; J Greenberger; J N Ihle
Characteristics of IL-3 derived and IL-3 dependent lymphocyte cell lines.
Advances in experimental medicine and biology 1982;149():719-24.
1981: John Lee; J N Ihle
Increased responses to lymphokines are correlated with preleukemia in mice inoculated with Moloney leukemia virus.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(12):7712-6.
1981: J N Ihle; John Lee; L Rebar
T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(6):2565-70.
1981: John Lee; L Enjuanes; L Cicurel; J N Ihle
T cell recognition of Moloney sarcoma virus proteins. II. Phenotypes of the different lymphocyte subpopulations producing and responding to blastogenic factors and their relative frequencies during tumor regression.
Journal of immunology (Baltimore, Md. : 1950) 1981;127(1):78-83.
1981: A J Hapel; John Lee; W L Farrar; J N Ihle
Establishment of continuous cultures of thy1.2+, Lyt1+, 2-T cells with purified interleukin 3.
Cell 1981;25(1):179-86.
1981: L Enjuanes; John Lee; J N Ihle
T cell recognition of Moloney sarcoma virus proteins during tumor regression. I. Lack of a requirement for macrophages and the role of blastogenic factors in T cell proliferation.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(4):1478-84.
1981: P J Fischinger; H J Thiel; J N Ihle; John Lee; J H Elder
Detection of a recombinant murine leukemia virus-related glycoprotein on virus-negative thymoma cells.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(3):1920-4.
1981: John Lee; I Horak; J N Ihle
Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(2):715-22.
1981: John Lee; J N Ihle
Chronic immune stimulation is required for Moloney leukaemia virus-induced lymphomas.
Nature 1981;289(5796):407-9.
1981: I Horak; L Enjuanes; John Lee; J N Ihle
Resistance of cultures of normal T cells to infection with murine type C viruses.
Journal of virology 1981;37(1):483-7.
1980: I Horak; John Lee; L Enjuanes; J N Ihle
Characterization of a unique defective type C virus associated with a Moloney leukemia virus-induced splenic T-cell lymphoma cell line.
Journal of virology 1980;36(2):299-308.
1980: L Cicurel; John Lee; L Enjuanes; J N Ihle
Monoclonal antibodies to the envelope proteins of Moloney leukemia virus: characterization of recombinant viruses.
Transplantation proceedings 1980;12(3):394-7.
1980: L E Benade; R H Bassin; J N Ihle; John Lee; Alan Rein
Isolation and characterization of a unique C57BL B-tropic virus.
Virology 1980;100(1):199-203.
1980: L Pepersack; John Lee; R McEwan; J N Ihle
Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(1):279-85.
1979: John Lee; J N Ihle
Mechanisms of C-type viral leukemogenesis. I. Correlation of in vitro lymphocyte blastogenesis to viremia and leukemia.
Journal of immunology (Baltimore, Md. : 1950) 1979;123(5):2351-8.
1979: L Enjuanes; John Lee; J N Ihle
Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex.
Journal of immunology (Baltimore, Md. : 1950) 1979;122(2):665-74.
1977: John Lee; J N Ihle
Characterization of the blastogenic and cytotoxic responses of normal mice to ecotropic C-type viral gp71.
Journal of immunology (Baltimore, Md. : 1950) 1977;118(3):928-34.
1977: J N Ihle; John Lee
The immune response of (C57BL/6 X C3H)F1 mice to the endogenous AKR-MuLV.
Medical microbiology and immunology 1977;164(1-3):207-16.
1977: John Lee; J N Ihle; R Huebner
The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(1):343-7.
1976: J N Ihle; J J Collins; John Lee; P J Fischinger; V Moennig; W Schäfer; M G Hanna; D P Bolognesi
Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice.
Virology 1976;75(1):74-87.
1976: J N Ihle; J J Collins; John Lee; P J Fischinger; N Pazmino; V Moennig; W Schäfer; M G Hanna; D P Bolognesi
Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. III. Influence on endogenous MuLV-mediated pathogenesis.
Virology 1976;75(1):102-12.
1976: J N Ihle; John Lee; J J Collins; P J Fischinger; N H Pazmino; V Moennig; W Schäfer; M G Hanna; D P Bolognesi
Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. II. Response in C57BL/6 mice.
Virology 1976;75(1):88-101.
1976: John Lee; J N Ihle
Inhibition of normal mouse lymphocyte mitogen responses by xenogeneic or allogeneic antibodies to the MuLV glycoprotein gp71.
Journal of immunology (Baltimore, Md. : 1950) 1976;117(3):1033-8.
1976: M G Hanna; J N Ihle; John Lee
Autogenous immunity to endogenous RNA tumor virus: humoral immune response to virus envelope antigens.
Cancer research 1976;36(2 pt 2):608-14.
1975: John Lee; J N Ihle
Autogenous immunity to endogenous RNA tumor virus: reactivity of natural immune sera to antigenic determinants of several biologically distinct murine leukemia viruses.
Journal of the National Cancer Institute 1975;55(4):831-8.
1974: John Lee; M G Hanna; J N Ihle; S A Aaronson
Autogenous immunity to endogenous RNA tumor virus: differential reactivities of immunoglobulins M and G to virus envelope antigens.
Journal of virology 1974;14(4):773-81.
1974: John Lee; M M Sigel
A differential effect of IgM and IgG antibodies on the blastogenic response of lymphocytes to rubella virus.
Cellular immunology 1974;13(1):22-31.